Connect with cross-disciplinary researchers from around the world and engage with experts at the leading global medical meeting on hypertension. Discover . AHA Hypertension Scientific Sessions 2025 is held in Baltimore MD, United States, from 9/4/2025 t
2025年美国心脏协会(AHA)血管发现科学会议:从基因到医学将于2025年4月22-25日在美国巴尔的摩举行,会议由美国心脏协会(AHA)动脉硬化、血栓形成和血管生物学委员会、外周血管疾病委员会、基因组与精准医学委员会合作组织。本次会议提供了难得的机会,可以使与会者与来自世界各地的具有广泛研究兴趣和专业知识的同事会面,及...
https://www.aha-engineers.com/presenting-2023-ma-commercial-energy-code-impacts/ Mon, 20 May 2024 19:14:41 +0000 https://www.aha-engineers.com/?p=2561 On May 15th, we presented AHA University: 2023 MA Commercial Energy Codes Impact “course” to VVA Project & Cost Managers. We love ...
The presentation at the 2023 AHA Hypertension Scientific Sessions, titled, “Aldosterone Synthase Inhibition with Lorundrostat for Uncontrolled Hypertension: The Target‐HTN Phase 2 Randomized Clinical Trial,” can be accessed on the public...
Spatial repellents (SRs) have been widely used for prevention of mosquito bites, but their efficacy in reducing Aedes-borne viruses (ABV) has not been tested rigorously at large scale in Asia. To address this knowledge gap, a trial to evaluate the effica
The annual American Heart Association (AHA) Scientific Sessions meeting for 2022 took place across 3 days in November, both virtually and in person in Chic... D Soundararajan - 《Drugs of the Future》 被引量: 0发表: 2023年 American Heart Association Scientific Sessions 2018. Martin J. Kuria...
In patients who have had a valve intervention, most cardiologists continue to see patients for a clinical history and physical examination at annual intervals, or more frequently if needed for symptoms or concurrent conditions. A baseline TTE study is recommended after all valve interventions, includi...
These awards are open to all residents, postdoctoral students, medical students and fellows who present at NASCI's Annual Meeting. This year, at the 41... Rybicki,J Frank - 《International Journal of Cardiovascular Imaging》 被引量: 0发表: 2013年 ...
The ACC/AHA/ASE/ASNC/ASPC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2023 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Chronic Coronary Disease document1 (https://www.jacc.org/doi/10.1016/j.jacc.2023.03.410) provides an updated review of the use of stress and anatomic di...
later developments with the FDA may be inconsistent with the feedback from the completed end of Phase 2 meeting, including whether the proposed pivotal program will support registration of lorundrostat which is a review issue with ...